Our results suggest that the CCR5/CCL5-dependent Treg recruitment to inflammation site in patients with type 1 diabetes may be impaired; however, a larger group of patients needs to be assessed to confirm this observation. This evidence concerns the gene CCR5 and type 1 diabetes mellitus.